ZS Pharma, Inc. Stock-Based Compensation
ZS Pharma, Inc. reported Stock-Based Compensation of $18.30 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2015-11-09
- ZS Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2015-09-30 was $6.11M, a 137.65% increase year-over-year.
- ZS Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2015-06-30 was $9.77M, a 377.09% increase year-over-year.
- ZS Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2015-03-31 was $2.42M, a 177.84% increase year-over-year.
- ZS Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2014-12-31 was $2.18M, a 7.13% increase year-over-year.
- ZS Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2014 was $7.67M, a 257.98% increase from fiscal 2013.
- ZS Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2013 was $2.14M, a 819.31% increase from fiscal 2012.
- ZS Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2012 was $233.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2015-09-30 | $6.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $15.88M derived: sum of 2 quarters · filed 2015-11-09 | $18.30M 10-Q · filed 2015-11-09 | $20.48M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | $9.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $12.19M 10-Q · filed 2015-08-06 | $14.37M derived: sum of 3 quarters · filed 2015-08-06 | $16.94M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-03-31 | $2.42M 10-Q · filed 2015-05-11 | $4.60M derived: sum of 2 quarters · filed 2015-05-11 | $7.17M derived: sum of 3 quarters · filed 2015-11-09 | $9.22M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $4.75M derived: sum of 2 quarters · filed 2015-11-09 | $6.80M derived: sum of 3 quarters · filed 2015-11-09 | $7.67M 10-K · filed 2015-03-13 |
| 2014-09-30 | $2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $4.62M derived: sum of 2 quarters · filed 2015-11-09 | $5.49M 10-Q · filed 2015-11-09 | $7.52M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $2.92M 10-Q · filed 2015-08-06 | $4.95M derived: sum of 3 quarters · filed 2015-08-06 | $4.97M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $871.00K 10-Q · filed 2015-05-11 | $2.90M derived: sum of 2 quarters · filed 2015-05-11 | $2.92M derived: sum of 3 quarters · filed 2015-05-11 | |
| 2013-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $2.05M derived: sum of 2 quarters · filed 2015-03-13 | $2.14M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $108.00K 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $92.00K 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $233.00K 10-K · filed 2015-03-13 |